To identify the specific USPs targeted by P22077 in CML cells, we measured the expression of substrates of USP7 and USP10, including p53, a substrate of both USP7 and USP1061,62, and SIRT6, a substrate of USP1063. This evidence concerns the gene TP53 and chronic myelogenous leukemia, BCR-ABL1 positive.